Physical Activity and CVD in Adolescents With Type 2 Diabetes
CVD
Physical Activity and Cardiovascular Disease (CVD) in Adolescents With Type 2 Diabetes: A Pilot Randomized Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The main research questions for this study are: (1) Is delivering a resiliency-informed behavioural intervention designed to increase physical activity (PA) feasible for adolescents living with Type 2 Diabetes (T2D)? and (2) What is the expected change in proposed cardiovascular outcomes after 12 weeks in both study arms? Qualitative and quantitative methods embedded in this pilot randomized trial will answer these questions and determine the feasibility of a larger randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Sep 2023
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2022
CompletedFirst Posted
Study publicly available on registry
February 13, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedMarch 16, 2023
March 1, 2023
4 months
December 22, 2022
March 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Enrollment rates
Defined as the number of adolescents who consent to participate and are randomized to one of the two study arms.
12 weeks
Adherence to the intervention arms
Defined as the percentage of prescribed sessions that adolescents/families attended during the trial.
12 weeks
Retention for follow-up measurements
Defined as the number of adolescents who complete follow-up measurements at randomization.
24 weeks
Secondary Outcomes (3)
Physical activity
week 1, week 12, week 24 (3 weeks total)
Readiness for behavior change
week 1, week 12, week 24 (measures will be taken at 3 different time points)
BREQ2 (Behavioral Regulation in Exercise Questionnaire-2) change
week 1, week 12, week 24 (measures will be taken at 3 different time points)
Study Arms (4)
Intervention_Winnipeg
EXPERIMENTALThe intervention arm will take place in a 12 week intervention (3 sessions per week) which will use a peer mentoring network based on the circle of courage to encourage adolescents with T2D to achieve the WHO recommended target of 300 minutes of moderate to vigorous PA weekly.
Control_Winnipeg
NO INTERVENTIONThe control group will receive standard recommendations for increasing daily PA from the Canadian Society of Exercise Physiology and the American Heart Association.
Intervention_STP
EXPERIMENTALThe intervention arm will take place in a 12 week intervention (3 sessions per week) which will use a peer mentoring network based on the circle of courage to encourage adolescents with T2D to achieve the WHO recommended target of 300 minutes of moderate to vigorous PA weekly.
Control_STP
NO INTERVENTIONThe control group will receive standard recommendations for increasing daily PA from the Canadian Society of Exercise Physiology and the American Heart Association.
Interventions
Participants will be asked to participate for 12 weeks, attending 3 sessions per week (if in the intervention arm). Session 1 will be a group session that will be about 90 minutes, session 2 will be an individual session with a peer mentor for 20-30 minutes, and session 3 will be a virtual check in with the peer mentor about 15 minutes. The intervention will focus on increasing physical activity through the circle of courage.
Eligibility Criteria
You may qualify if:
- years old
- BMI z score \>1.6
- diagnosed with type 2 diabetes
You may not qualify if:
- engage in \>300 minutes of moderate-vigorous physical activity per week
- have diabetes because of surgery or medications for another condition
- use chronic high dose steroids or immunosuppressive therapy
- they have cancer
- the have evidence of drug or alcohol abuse
- if youth and/or parent/guardian are unable or unwilling to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Manitoba / Children's Hospital Research Institute of Manitoba (CHRIM)
Winnipeg, Manitoba, R3E3P4, Canada
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 22, 2022
First Posted
February 13, 2023
Study Start
September 1, 2023
Primary Completion
December 20, 2023
Study Completion
December 20, 2023
Last Updated
March 16, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share